Shareholder And Patent Attorney
CurrentRepresentative Matters:• Developed world-wide patent strategy for early-stage biotech company in the area of nucleic acid-based therapeutics • Advised synthetic biology company on developing patent strategy for engineered enzymes• Advised early-stage companies in the foodtech and agtech spaces.• Prosecuted patent families related to antibodies and recombinant proteins • Developed world-wide patent portfolio related to mRNA vaccine and counseled client on patent term extension (PTE) for mRNA vaccines• Counseled biotech/pharma companies on strategy for biosimilar product development• Provided IP due diligence and regulatory analysis for multiple biotech/pharma transactions• Advised clients on inter partes review (IPR) strategy, including representing Patent Owner in an IPR proceeding. Obtained denial of institution.• Successfully represented Patent Owner in achieving denial of institution of four IPR proceedings in RNA interference technology• Conducted pre-suit investigation involving analysis of competitor’s biologic to demonstrate infringement of client’s claims • Successfully appealed written description rejection of antibody claims to the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office
